Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Lymphoma

Free Subscription 27.07.2026 1 Am J Hematol 2 Blood 1 BMC Neurol 1 Bone Marrow Transplant 1 Br J Dermatol 1 Br J Haematol 1 Cancer 1 Eur J Haematol 5 Haematologica 2 J Am Acad Dermatol 1 Leuk Lymphoma 1 Neurology 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. HU S, Liu W, Zhao L, Huang W, et al
   Upfront Autologous Stem Cell Transplantation in First Complete Remission for Advanced-Stage Extra-Nodal NK/T-Cell Lymphoma: A Multicenter Retrospective Study.
   Am J Hematol. 2026 Jul 20. doi: 10.1002/ajh.70415.
   PubMed         Abstract available
   
   

   
   Blood

2. 
   Domostegui A, Peddigari S, Mercer CA, et al. Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death. Blood. 2021;137(24):3351-3364.
   Blood. 2026;148:640.
   PubMed        
   
   
3. ARAUJO-AYALA F, Ros M, Alexandru R, Mateos-Jaimez J, et al
   CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma.
   Blood. 2026 Jul 22:blood.2025032663. doi: 10.1182/blood.2025032663.
   PubMed         Abstract available
   
   

   
   BMC Neurol

4. DEMIR IY, Kilic AK, Barut BO
   Facial diplegia as the first manifestation of Burkitt lymphoma with a Guillain-Barre syndrome-like presentation: a case report.
   BMC Neurol. 2026 Jul 18. doi: 10.1186/s12883-026-05153.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

5. SHEN YG, Chen SY, Mu RJ, Li HY, et al
   Chidamide?augmented BEAM conditioning and maintenance in first-remission T?cell lymphoma: a single?arm phase 2 experience.
   Bone Marrow Transplant. 2026 Jul 18. doi: 10.1038/s41409-026-02992.
   PubMed        
   
   

   
   Br J Dermatol

6. MURAT DE MONTAI Q, Bourrat E, Battesti G, Hickman G, et al
   Cutaneous T-cell lymphoma in the setting of NIPAL4-related nonsyndromic epidermal differentiation disorder: three cases.
   Br J Dermatol. 2026 Jul 22:ljag302. doi: 10.1093.
   PubMed        
   
   

   
   Br J Haematol

7. MAKHANI S, Tudor T, Luttwak E, Alhomoud M, et al
   Immunoglobulin replacement after chimeric antigen receptor T-cell therapy in large B-cell lymphoma with hypogammaglobulinaemia: Secondary Center for International Blood and Marrow Transplant Research analysis.
   Br J Haematol. 2026 Jul 22. doi: 10.1111/bjh.70696.
   PubMed        
   
   

   
   Cancer

8. GIBRAN-NUNES F, Pecego H, Santos J, Nunes Y, et al
   Outcomes of loncastuximab tesirine in heavily pretreated patients with diffuse large B-cell lymphoma, including the post-CAR T-cell therapy setting: A meta-analysis.
   Cancer. 2026;132:e70543.
   PubMed         Abstract available
   
   

   
   Eur J Haematol

9. SAMPERIO VM, Hamoud M, Ike I, Dasanu CA, et al
   Mantle Cell Lymphoma in Geriatric Patients: Biologic Risk Stratification, Fitness-Adapted Strategies, and Unmet Needs.
   Eur J Haematol. 2026 Jul 21. doi: 10.1111/ejh.70272.
   PubMed         Abstract available
   
   

   
   Haematologica

10. WANG W, Liu D, Wei H, Wang H, et al
    Comprehensive evaluation of safety and efficacy: TEAM versus BEAM as conditioning for autologous transplantation in patients with lymphoma.
    Haematologica. 2026 Jul 23. doi: 10.3324/haematol.2026.301018.
    PubMed         Abstract available
    
    
11. JOHANSSON A, Nilsson D, Wikstrom F, Olsson LM, et al
    Integrated spatially guided transcriptomics and multiplex imaging identify a high-risk CD163+/CD11c-subgroup in diffuse large B-cell lymphoma.
    Haematologica. 2026 Jul 23. doi: 10.3324/haematol.2025.300429.
    PubMed         Abstract available
    
    
12. ILLIDGE T, Wilson W, Paterson J, Bates A, et al
    Final results of UK NCRI phase II trial of pembrolizumab and radiotherapy in cutaneous T cell lymphoma.
    Haematologica. 2026 Jul 23. doi: 10.3324/haematol.2025.288878.
    PubMed         Abstract available
    
    
13. DAY JR, Ansell SM
    Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.
    Haematologica. 2026 Jul 23. doi: 10.3324/haematol.2026.301267.
    PubMed         Abstract available
    
    
14. JIN Y, Fang Y, Yao Y
    Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin
    Haematologica. 2026 Jul 23. doi: 10.3324/haematol.2026.301607.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

15. CHEN C, Zhou MH, Sacknovitz Y, Ramush G, et al
    Health disparities in narrowband UVB phototherapy for mycosis fungoides: A multi-institutional cohort study across Fitzpatrick skin types.
    J Am Acad Dermatol. 2026;95:441-449.
    PubMed         Abstract available
    
    
16. LOHRAY R, Purnak S, Huen A, Duvic M, et al
    Long-term outcomes in juvenile-onset mycosis fungoides.
    J Am Acad Dermatol. 2026;95:409-415.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

17. AGHAZADA S, Goksel S, Ozturk H, Eroglu Kucukdiler AH, et al
    Baseline whole-body metabolic tumor volume as an independent prognostic marker in diffuse large B-cell lymphoma: a PET/cT-based study.
    Leuk Lymphoma. 2026 Jul 23:1-12. doi: 10.1080/10428194.2026.2701956.
    PubMed         Abstract available
    
    

    
    Neurology

18. HORTA L, de Souza BLV, Martinez-Lage M, Forst D, et al
    Characterization of Clinical Course, Diagnosis, Treatment, and Outcomes of Intravascular Lymphoma With Neurologic Involvement.
    Neurology. 2026;107:e210199.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

19. MA N, Bose D, Svoboda J, Chong EA, et al
    FGFR2 is an oncogenic driver critical for successful human gammaherpesvirus latent infection and oncogenesis.
    Proc Natl Acad Sci U S A. 2026;123:e2602413123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum